* JPM PACIFIC EQUITY D (ACC) USD | 23/10 | 14,08% |
| ** JPM PACIFIC EQUITY I2 (ACC) EUR | 23/10 | 15,55% |
| ** JPM PACIFIC EQUITY I2 (ACC) USD | 23/10 | 15,83% |
| ** JPM PACIFIC EQUITY I (ACC) USD | 23/10 | 15,56% |
| * JPM SGD LIQUIDITY LVNAV AGENCY (DIST) | 23/10 | 5,56% |
| *** JPM SGD LIQUIDITY LVNAV C (ACC) | 23/10 | 6,50% |
| * JPM SGD LIQUIDITY LVNAV C (DIST) | 23/10 | 5,56% |
| ND JPM SGD LIQUIDITY LVNAV CORE (DIST) | 23/10 | 5,56% |
| *** JPM SGD LIQUIDITY LVNAV E (ACC) | 23/10 | 6,60% |
| * JPM SGD LIQUIDITY LVNAV E (DIST) | 23/10 | 5,56% |
| * JPM SGD LIQUIDITY LVNAV INSTITUTIONAL (DIST) | 23/10 | 5,56% |
| ***** JPM TAIWAN A (ACC) EUR | 22/10 | 73,42% |
| ***** JPM TAIWAN A (ACC) USD | 22/10 | 73,56% |
| ***** JPM TAIWAN A (DIST) USD | 22/10 | 73,47% |
| ***** JPM TAIWAN C (ACC) USD | 22/10 | 74,77% |
| ***** JPM TAIWAN C (DIST) USD | 22/10 | 73,70% |
| ***** JPM TAIWAN D (ACC) USD | 22/10 | 72,15% |
| ***** JPM TAIWAN I (ACC) EUR | 22/10 | 74,66% |
| ***** JPM TAIWAN I (ACC) USD | 22/10 | 74,80% |
| ** JPM THEMATICS-GENETIC THERAPIES A (ACC) CHF (HEDGED) | 23/10 | 15,04% |
| ** JPM THEMATICS-GENETIC THERAPIES A (ACC) EUR (HEDGED) | 23/10 | 15,94% |
| ** JPM THEMATICS-GENETIC THERAPIES A (ACC) USD | 23/10 | 22,46% |
| ** JPM THEMATICS-GENETIC THERAPIES A (DIST) CHF (HEDGED) | 23/10 | 15,04% |
| ** JPM THEMATICS-GENETIC THERAPIES A (DIST) EUR (HEDGED) | 23/10 | 15,90% |
| ** JPM THEMATICS-GENETIC THERAPIES A (DIST) USD | 23/10 | 22,41% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (ACC) CHF (HEDGED) | 23/10 | 15,59% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | 23/10 | 16,44% |
| *** JPM THEMATICS-GENETIC THERAPIES C2 (ACC) GBP (HEDGED) | 23/10 | 22,94% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (ACC) USD | 23/10 | 23,00% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (DIST) CHF (HEDGED) | 23/10 | 15,20% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (DIST) EUR (HEDGED) | 23/10 | 16,08% |
| *** JPM THEMATICS-GENETIC THERAPIES C2 (DIST) GBP (HEDGED) | 23/10 | 22,49% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (DIST) USD | 23/10 | 22,61% |
| ** JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | 23/10 | 16,32% |
| ** JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | 23/10 | 22,88% |
| ** JPM THEMATICS-GENETIC THERAPIES C (DIST) GBP | 23/10 | 22,33% |
| ** JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | 23/10 | 22,61% |
| ** JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | 23/10 | 15,01% |
| ** JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | 23/10 | 21,44% |
| ** JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | 23/10 | 16,48% |
| ** JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | 23/10 | 23,03% |
| ** JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | 23/10 | 22,63% |
| ** JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | 23/10 | 16,38% |
| ***** JPM TOTAL EMERGING MARKETS INCOME A (ACC) EUR | 23/10 | 13,24% |
| ***** JPM TOTAL EMERGING MARKETS INCOME A (ACC) USD | 23/10 | 13,51% |
| ** JPM TOTAL EMERGING MARKETS INCOME A (DIST) EUR | 23/10 | 10,55% |
| * JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | 23/10 | 8,59% |
| ***** JPM TOTAL EMERGING MARKETS INCOME C (ACC) EUR | 23/10 | 13,93% |
| **** JPM TOTAL EMERGING MARKETS INCOME D (ACC) EUR | 23/10 | 12,64% |
| **** JPM TOTAL EMERGING MARKETS INCOME D (ACC) USD | 23/10 | 12,91% |
